iterativehealth
Director, Site Performance & Solutions (Cardiology)
At a Glance
- Location
- Cambridge, Massachusetts, United States, New York, New York, United States
- Experience
- 10+ years
- Posted
- 2026-05-06T12:36:07-04:00
Key Requirements
Domain Knowledge
- Clinical
Requirements
10+ years of clinical research experience
Demonstrated proficiency with clinical research systems and tools, including CTMS and pre-screening workflows
Proven people management experience, with a track record of leading, developing, and holding accountable clinical research teams
Prior experience in a director-level or senior management role within a site network, CRO, or health tech organization
Cardiology-specific clinical research experience
At Iterative Health, we’re actively working towards creating an environment that is representative of the diversity of patients our technology serves.
Responsibilities
As the Director, Site Performance & Solutions (Cardiology), you will report to the VP, Growth and serve as the owner of Iterative Health's central clinical services that are delivered to our cardiology research sites as performance-enabling solutions, including pre-screening, regulatory support, and eSource.
Your mandate is to oversee, optimize, and continuously improve these service offerings so that our sites enroll faster, operate better, and achieve stronger trial outcomes
Network Performance Ownership
Serve as the single accountable owner for trial performance across IH's cardiology site network
Monitor site and network-level performance metrics continuously, identifying trends, gaps, and risks before they escalate
Service Deployment & Performance Improvement
About the Company
Iterative Health is a healthcare technology and services company powering the acceleration of clinical research to transform patient outcomes. The Iterative Health Site Network is a premier network of 100+ clinical research sites across the US and Europe, accelerating the path to market for novel therapies. By combining deep expertise in clinical trials with cutting-edge AI, we empower research teams and study sponsors to expand and expedite access to novel therapeutics for patients in need.